Fig. 6From: Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE RegistryClinical outcomes in polysensitized and non-polysensitized patients. Time-dependent changes in ACT, severe exacerbations, FeNO, and FEV1 in relation to polysensitization at baseline (analysis: GLM, Wilcoxon signed-rank test)Back to article page